Dados B3 › PATI3
PATI3 (Panatlantica): has profit grown?
PATI3 (Panatlantica): in 2025, net income attributable to controlling shareholders was R$ 49.9 million, down 41% versus 2024 (a profit of R$ 84.7 million); five years earlier (2020), a profit of R$ 182.5 million.
| Year | Profit (loss) | Change |
|---|---|---|
| 2025 | R$ 49.9 million | down 41% |
| 2024 | R$ 84.7 million | up 531% |
| 2023 | R$ 13.4 million | down 76% |
| 2022 | R$ 55.7 million | down 81% |
| 2021 | R$ 293.3 million | up 61% |
| 2020 | R$ 182.5 million | up 924% |
| 2019 | R$ 17.8 million | down 72% |
| 2018 | R$ 64.2 million | up 272% |
| 2017 | R$ 17.3 million | up 17% |
| 2016 | R$ 14.8 million | — |
Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/PATI3/fatos - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: PATI3.
Dividends · Debt · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:12 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:12 UTC. If this does not match /saude, you are reading a cached copy.